Outsourced Pharma App Notes & Case Studies
-
Patient Adherence With A Novel Dosage Form
11/13/2025
A sprinkle formulation helps patients with tremors or dysphagia take medication more easily, improving adherence, comfort, and care through a novel, FDA-approved oral granule format.
-
Seed Train Intensification Using High Cell Density Cryopreservation
8/11/2025
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based Formulations
3/20/2026
Develop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials.
-
Yeast Extracts: Improving Expression
4/17/2026
Yeast extract improves E. coli protein production by over 50%, boosts desired protein attributes 4X, and offers a secure animal-free nutrient source.
-
Get Up To 4X Titer With N-1 Perfusion
5/26/2026
N-1 perfusion improves antibody production by increasing cell density, optimizing media and conditions, boosting yields up to 4.5× while maintaining quality and reducing manufacturing time and costs.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
In Vivo RNA Tuning For Liver Gene Editing Efficiency
10/28/2025
RNA sequence and guide modifications, delivery platform design, and dose optimization all contribute to improved gene editing outcomes, which offers a clearer path toward safer, more potent, and scalable mRNA-based therapeutics.
-
Understanding Technology Transfer In Pharmaceutical Contract Manufacturing
10/16/2024
Technology transfer is a crucial process in the pharmaceutical industry, ensuring drugs developed in labs can be manufactured consistently at scale.
-
Best Practices For Oncolytic Virus Design, Development, Manufacturing
3/12/2025
Oncolytic viruses have the potential to revolutionize standard cancer treatment, but their continued progress hinges on meeting a number of goals linked to safety, efficacy, and commercial scale-up.
-
Producing Quality APIs At Scale
5/7/2026
Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.